Abivax SA Sponsored ADR
ABVX Healthcare Biotechnology
In the quarter to June 2026, EPS fell 98.8%, free cash flow fell 48.3% and total debt fell 98.5%, each against the same quarter a year earlier.
Follow ABVX
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Gross Profit |
+8 more quarters Free account |
— | — | — | — |
R&D Expenses |
64.78 | 51.07 | 57.98 | 67.83 | |
SG&A Expenses |
31.96 | 30.96 | 9.40 | 31.37 | |
Operating Income |
(94.34) | (81.54) | (65.81) | (97.80) | |
Non-operating Interest Expenses |
108.77 | 4.43 | 5.58 | 51.31 | |
Non-operating Income/Expense |
(84.92) | (2.72) | 9.35 | (45.81) | |
| (179.26) | (84.26) | (56.46) | (143.60) | ||
Income Tax Provision |
— | — | 0.27 | (7.06) | |
Income after Tax |
(179.26) | (90.87) | (56.73) | (136.54) | |
Net Income Common |
(179.26) | (90.87) | (56.73) | (136.54) | |
EPS (Basic) |
(2.45) | (1.19) | (0.71) | (1.71) | |
EPS (Diluted) |
(2.45) | (1.19) | (0.71) | (1.71) | |
Shares (Basic, Weighted) |
72.94 | 69.53 | 78.96 | 79.65 | |
Shares (Diluted, Weighted) |
72.94 | 69.53 | 78.96 | 79.65 | |
EBIT Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
EBT margin |
0.00% | 0.00% | 0.00% | 0.00% | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
EBITDA |
(94.01) | (81.25) | (65.38) | (97.36) | |
EBIT |
(94.34) | (81.54) | (65.81) | (97.80) | |
Income from Continuous Operations |
(179.26) | (90.87) | (56.73) | (136.54) | |
Consolidated Net Income/Loss |
(179.26) | (90.87) | (56.73) | (136.54) | |
EPS (Basic, from Continuous Ops) |
(2.46) | (1.27) | (0.72) | (1.71) | |
EPS (Diluted, from Cont. Ops) |
(2.46) | (1.27) | (0.72) | (1.71) | |
EPS (Basic, Consolidated) |
(2.46) | (1.27) | (0.72) | (1.71) | |
EPS (Diluted, Consolidated) |
(2.46) | (1.27) | (0.72) | (1.71) | |
Shares (Diluted, Average) |
72.94 | 69.53 | 78.96 | 79.65 | |
EBITDA Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating Cash Flow Margin |
0.00% | 0.00% | 0.00% | 0.00% |